Sequencing Novel Agents in Frontline and Second-Line Treatment of Hodgkin Lymphoma

被引：0
|
作者：
Moskowitz, Alison J. [1 ]
机构：
[1] Mem Sloan Kettering Canc Ctr, New York, NY 10065 USA
来源：
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2022年 / 22卷
关键词：
Brentuximab vedotin; nivolumab; pembrolizumab; Hodgkin lymphoma; BRENTUXIMAB VEDOTIN; SINGLE-CENTER; CHEMOTHERAPY; CARBOPLATIN; ETOPOSIDE; THERAPY; STAGE;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S101 / S103
页数：3
相关论文
共 50 条
  • [1] Sequencing novel agents in the treatment of classical Hodgkin lymphoma
    Ferhanoglu, Burhan
    Ozbalak, Murat
    [J]. EXPERT REVIEW OF HEMATOLOGY, 2023, 16 (12) : 991 - 1015
  • [2] Promising new second-line therapy for Hodgkin lymphoma
    Gourd, Elizabeth
    [J]. LANCET ONCOLOGY, 2019, 20 (02): : E76 - E76
  • [3] Optimizing Second-Line Therapy for Hodgkin Lymphoma: A Work in Progress
    Bartlett, Nancy L.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (28) : 3097 - +
  • [4] Novel agents for the treatment of Hodgkin lymphoma
    Dumaswala, Komal
    Mehta, Amitkumar
    [J]. EXPERT REVIEW OF HEMATOLOGY, 2015, 8 (05) : 659 - 667
  • [5] Improving second-line therapy in aggressive non-Hodgkin's lymphoma
    Gisselbrecht, C
    Mounier, N
    [J]. SEMINARS IN ONCOLOGY, 2004, 31 (01) : 12 - 16
  • [6] Integrating Novel Agents into the Treatment of Classic Hodgkin Lymphoma
    LaCasce, Ann S.
    [J]. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2021, 21 : S166 - S167
  • [7] Second-line treatment for primary central nervous system lymphoma
    M Reni
    A J M Ferreri
    E Villa
    [J]. British Journal of Cancer, 1999, 79 : 530 - 534
  • [8] NEW SECOND-LINE TREATMENT FOR B-CELL LYMPHOMA
    Aschenbrenner, Diane S.
    [J]. AMERICAN JOURNAL OF NURSING, 2022, 122 (08) : 23 - 23
  • [9] Targeted agents for second-line treatment of advanced hepatocellular carcinoma
    Personeni, Nicola
    Pressiani, Tiziana
    Bozzarelli, Silvia
    Rimassa, Lorenza
    [J]. WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2019, 11 (10) : 788 - 803
  • [10] Targeted agents for second-line treatment of advanced hepatocellular carcinoma
    Nicola Personeni
    Tiziana Pressiani
    Silvia Bozzarelli
    Lorenza Rimassa
    [J]. World Journal of Gastrointestinal Oncology, 2019, (10) : 788 - 803
12345